Publications

Xing D, Decker WK, Li S, Robinson SN, Yang H, Segal H, O'Connor S, Yao X, Komanduri KV, McMannis JD, Jones RB, de Lima M, Champlin RE, Shpall EJ. AML-loaded DC generate Th1-type cellular immune responses in vitro. Cytotherapy. 2006. PMID: 16698683


Li Zhang, Bhramar Mukherjee, Malay Ghosh and Rongling Wu.. A Bayesian Framework for Genetic Association in Case-Control Studies: Accounting for Unknown Population Substructure Statistical Modeling. 2006. PMID:


Hruban RH, Rustgi AK, Brentnall TA, Tempero MA, Wright CV, Tuveson DA. Pancreatic cancer in mice and man: the Penn Workshop 2004. Cancer research. 2006. PMID: 16397208


Parmar S, Robinson SN, Komanduri K, St John L, Decker W, Xing D, Yang H, McMannis J, Champlin R, de Lima M, Molldrem J, Rieber A, Bonyhadi M, Berenson R, Shpall EJ. Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity. Cytotherapy. 2006. PMID: 16698688


Malay Ghosh, Li Zhang and Bhramar Mukherjee.. Equivalence of Posteriors in the Bayesian Analysis of The Multinomial-Poisson Transformation Metron - International Journal of Statistics. 2006. PMID:


Riker AI, Jove R, Daud AI. Immunotherapy as part of a multidisciplinary approach to melanoma treatment. Frontiers in bioscience : a journal and virtual library. 2006. PMID: 16146709


Komanduri KV, Couriel D, Champlin RE. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006. PMID: 16399595


Rosenberg JE, Galsky MD, Rohs NC, Weinberg VK, Oh WK, Kelly WK, Small EJ. A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy. Cancer. 2006. PMID: 16329138


Bivona TG, Quatela S, Philips MR. Analysis of Ras activation in living cells with GFP-RBD. Methods in enzymology. 2006. PMID: 16757320


Schmidt B, Fujimura SH, Martin JN, Levy JA. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. Journal of clinical immunology. 2006. PMID: 16418803


Wang HR, Ogunjimi AA, Zhang Y, Ozdamar B, Bose R, Wrana JL. Degradation of RhoA by Smurf1 ubiquitin ligase. Methods in enzymology. 2006. PMID: 16472676


Bergsland EK. When does the presence of the target predict response to the targeted agent? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005. PMID: 16365177


Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer research. 2005. PMID: 16357174


Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast cancer research : BCR. 2005. PMID: 16417656


Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005. PMID: 16344320


Kim TH, Daud A, Ude AO, DiGiorgi M, Olivero-Rivera L, Schrope B, Davis D, Inabnet WB, Bessler M. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surgical endoscopy. 2005. PMID: 16341569


Beckwith J, Huang F. Should we make a fuss? A case for social responsibility in science. Nature biotechnology. 2005. PMID: 16333283


Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 2005. PMID: 16247788


Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN. In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates. Molecular cancer therapeutics. 2005. PMID: 16373714


Marchion DC, Bicaku E, Turner JG, Daud AI, Sullivan DM, Munster PN. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005. PMID: 16322310